跳至主要内容
临床试验/NL-OMON39717
NL-OMON39717已完成不适用

ChoCar trial; The role of gut microbiota in choline and carnitine metabolism on vascular inflammation in metabolic syndrome - ChoCar

Academisch Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Subjects: Kaukasian, adult, obese males with BMI >30 kg/m2 and metabolic syndrome, including increased fasting glucose
  • Donors: healthy, adult, lean males (BMI 20-25 kg/m2) on a vegetarian diet

排除标准

  • Supplement use (including vitamin/choline/carnitine supplements, energy drinks and carnitine-enriched soymilk); a medical history of a cardiovascular event (myocardial infarction or stroke) or cholecystectomy; use of medication including antacids and oral antibiotics in the past three months; (expected) prolonged compromised immunity (e.g. due to recent cytotoxic chemotherapy or HIV-infection with a CD4 count < 240).

研究者

相似试验